SCHEMBL11143638

SCHEMBL11143638

CCCCOCCOC(=O)C(=O)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.53
▸ RAB9A P51151 4/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ MAPT P10636 5/20 0.50
▸ ADORA3 P0DMS8 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ STAT1 P42224 1/20 0.50
▸ APP P05067 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ HDAC1 Q13547 2/20 0.49
▸ HDAC2 Q92769 2/20 0.49
▸ ELOVL1 Q9BW60 1/20 0.49
▸ PKM P14618 1/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11137105 0.94 PARP1 (0.55) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11120333 0.90 PARP1 (0.59) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11140728 0.85 NPC1 (0.62) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11139118 0.84 PARP1 (0.69) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11141502 0.83 ELOVL1 (0.60) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11136421 0.82 POLB (0.57) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11141185 0.82 PARP1 (0.54) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL10519957 0.81 PARP1 (0.49) PARP1RAB9ANPC1CASP3SENP7
SCHEMBL11136396 0.81 SMN1; SMN2 (0.61) RAB9ANPC1MAPTADORA3ALDH1A1
SCHEMBL11142941 0.81 RAB9A (0.57) PARP1RAB9ANPC1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4407810-A TREATMENT OF ALLERGIC DISORDERS BASF AKTIENGESELLSCHAFT (DE) 1983-10-04 — — US disclosed
EP-0044442-A1 N-(4-Phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound BASF Aktiengesellschaft (DE) 1982-01-27 — — EP disclosed
Send feedback